(Q37346118)

19 August 2017

Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction (English)

1 reference

19 August 2017

Bridgette A Kanz

1

1 reference

19 August 2017

Megan H Pollack

2

1 reference

19 August 2017

Romany Johnpulle

3

1 reference

19 August 2017

Igor Puzanov

4

1 reference

19 August 2017

Leora Horn

5

1 reference

19 August 2017

Alicia Morgans

6

1 reference

19 August 2017

Jeffrey A Sosman

7

1 reference

19 August 2017

Suthee Rapisuwon

8

1 reference

19 August 2017

R Martin Conry

9

1 reference

19 August 2017

Zeynep Eroglu

10

1 reference

19 August 2017

Douglas B Johnson

11

1 reference

19 August 2017

18 October 2016

1 reference

Journal for Immunotherapy of Cancer

19 August 2017

1 reference

19 August 2017

4

1 reference

19 August 2017

60

1 reference

Tumor Regression and Allograft Rejection after Administration of Anti-PD-1

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5067899

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5067899

Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5067899

PD-1 Blockade in Advanced Melanoma in Patients with Hepatitis C and/or HIV.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5067899

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5067899

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5067899

Pembrolizumab for the treatment of non-small-cell lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5067899

Pembrolizumab versus Ipilimumab in Advanced Melanoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5067899

Nivolumab in previously untreated melanoma without BRAF mutation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5067899

Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5067899

Clinical pharmacokinetics of therapeutic monoclonal antibodies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5067899

The pharmacokinetics and pharmacodynamics of monoclonal antibodies--mechanistic modeling applied to drug development.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5067899

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5067899

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5067899

Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5067899

Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5067899

Report of ipilimumab in a heart transplant patient with metastatic melanoma on tacrolimus

20 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27777770

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/S40425-016-0166-5

0 references

Dimensions Publication ID

0 references

1 reference

19 August 2017

PubMed publication ID

27777770

1 reference